We have limited capital, as your previous witness said, so our objective is really to build a portfolio of innovative projects because, by nature, some innovative projects fail and some succeed. Our view is that we need to try many things. If we were to fund entirely the projects that we get into—and we would fund some—we would try fewer than we are now. I think the help from government helps us do that, to try many things from the laboratory to commercialization. That's the strategy we're adopting, and that's why we think government funding is so important. It allows us to try many technologies so that for the ones that work, we have not failed to try because of lack of funding.
Specifically on your question on TMP-Bio, the technology will benefit the entire industry. We've decided to participate in the funding of the commercialization or the piloting, so to speak, because to us there's a particular interest in trying to reuse thermomechanical pulping assets, which is what we use to make newsprint. Particularly for us, strategically, if this technology is successful and can be commercialized, then we have a lot to gain because we'll be making products that we could potentially sell at large volumes. A lot of our existing facilities that produce traditional paper grades use thermomechanical pulping technology; therefore, the replication potential for us, if successful, is extremely interesting. That's why we've participated, but the result of the research and development is going to be shared within the industry.
Perhaps you're not as familiar with FPInnovations, and maybe that's where your question comes from. FPInnovations is a membership-based organization. The R and D portion of the $21 million is essentially funded and conducted by FPInnovations, and all members will have access to it.